← Back
$MBRX All transactions

Moleculin Biotech, Inc.

▲ BUY
7 / 10

Conviction

$ Value

Shares

2,027,025

Price

Filed

Jun 23

Why this score? (7/10)
  • Open market buy (+3)
  • C-suite insider (+2)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

KLEMP WALTER V

Title

CEO and President

CIK

0000938419

Roles

Director Officer

Transaction Details

Transaction Date

2025-06-23

Code

P

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

2,409,481

Footnotes

Restricted stock units convert into common stock on a one-for-one basis. | Shares withheld for payment of taxes upon vesting of restricted stock unit awards. | On June 20, 2022, the reporting person was granted 15,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. | On June 22, 2023, the reporting person was granted 35,959 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. | On June 23, 2025, the reporting person acquired 675,675 shares of common stock and Series E warrants to purchase 2,027,025 shares of common stock at a purchase price of $0.37 per share and accompanying warrants in a public offering. The Series E warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Series E warrants and will expire five years from the date of such approval.

Filing Info

Accession No.

0001437749-25-021050

Form Type

4

Issuer CIK

0001659617

KLEMP WALTER V's History

Date Ticker Type Value
2025-11-12 MBRX A
2025-11-12 MBRX A
2025-11-04 MBRX M
2025-11-04 MBRX F $3K
2025-11-04 MBRX M $0
2025-08-11 AMIX D
2025-06-23 MBRX $250K
2025-06-23 MBRX
2025-06-22 MBRX M
2025-06-22 MBRX F $585

Other Insiders at MBRX (90d)

No other insider activity at this issuer in the last 90 days.